Skip to Content

35 Results Found

  • Article
  • Open Access
11 Citations
4,461 Views
15 Pages

High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan

  • Cheng-Chih Tsai,
  • Yung-Cheng Su,
  • Oluwaseun Adebayo Bamodu,
  • Bo-Jung Chen and ,
  • Wen-Chiuan Tsai,
  • Wei-Hong Cheng,
  • Chii-Hong Lee,
  • Shu-Min Hsieh,
  • Mei-Ling Liu and
  • Tsu-Yi Chao
  • + 19 authors+ 14 authors

31 March 2021

This study investigated the epidemiological and clinical peculiarities of BCL2 and BCL6 rearrangement in patients with high grade B-cell lymphoma (HGBL) from Taiwan, compared with data from Western countries. Two hundred and eighty-two DLBCL cases fr...

(This article belongs to the Special Issue B Cell Lymphoma)
  • Article
  • Open Access
3 Citations
3,098 Views
16 Pages

The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa

  • Stine Dahl Vest,
  • Patrick Rene Gerhard Eriksen,
  • Fleur A. de Groot,
  • Ruben A. L. de Groen and ,
  • Anne H. R. Kleij,
  • Marina Knudsen Kirkegaard,
  • Peter Kamper,
  • Peter Kristian Rasmussen,
  • Christian von Buchwald and
  • Steffen Heegaard
  • + 8 authors+ 3 authors

To provide insights into targetable oncogenic pathways, this retrospective cohort study investigated the genetic profile of 26 patients with diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS), and two patients with high-grade B-cell l...

(This article belongs to the Special Issue Advances in Molecular Understanding of Ocular Adnexal Disease)
  • Article
  • Open Access
23 Citations
4,403 Views
25 Pages

Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential

  • Rune Matthiesen,
  • Paula Gameiro,
  • Andreia Henriques,
  • Cristian Bodo and ,
  • Maria Carolina Strano Moraes,
  • Bruno Costa-Silva,
  • José Cabeçadas,
  • Maria Gomes da Silva,
  • Hans Christian Beck and
  • Ana Sofia Carvalho
  • + 5 authors+ 0 author

1 November 2022

Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell lymphoma characterized by a heterogeneous behavior and in need of more accurate biological characterization monitoring and prognostic tools. Extracellular vesicles are secreted by all cell...

(This article belongs to the Special Issue The Role of Exosomes in Cancer Diagnosis and Therapy)
  • Article
  • Open Access
826 Views
21 Pages

Pathogenic Mutations in the Tumor Microenvironment Drive Tumor Progression in Diffuse Large B-Cell Lymphoma Through Tumor–Stroma Cross-Talk

  • Vaishali Aggarwal,
  • Radhika Srinivasan,
  • Amanjit Bal,
  • Pankaj Malhotra and ,
  • Subhash Varma and
  • Ashim Das
  • + 1 author+ 0 author

22 May 2026

Background: Diffuse Large B-cell Lymphoma (DLBCL) is a biologically heterogeneous subtype of non-Hodgkin’s lymphoma (NHL), accounting for 30–40% of cases worldwide. Despite the incorporation of rituximab into standard chemo-immunotherapy...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
2 Citations
3,962 Views
11 Pages

Molecular Classification of Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma Cases and Association with Outcomes in Morocco

  • Mahat Taybi,
  • Zineb Khammar,
  • Noufissa Alami Drideb,
  • Rhizlane Berrady and ,
  • Sanae Benmiloud,
  • Laila Bouguennouch,
  • Sanae Elfakir,
  • Laila Tahiri,
  • Mohammed Majdoub and
  • Nawal Hammas
  • + 6 authors+ 1 author

8 October 2024

Background: High-grade B-cell lymphoma with c-MYC and BCL2 and/or BCL6 rearrangements (HGBL-DHL/THL) is a recently identified category in the most recent World Health Organization (WHO) classification. For all tumors displaying the appearance of diff...

(This article belongs to the Section Lymphomas)
  • Feature Paper
  • Article
  • Open Access
14 Citations
4,932 Views
18 Pages

Prognostic Significance of p53 and p63 in Diffuse Large B-Cell Lymphoma: A Single-Institution Experience

  • Juan Carlos Alvarez Moreno,
  • Hisham F. Bahmad,
  • Abed Alhalim Aljamal,
  • Ruben Delgado and ,
  • Ali Salami,
  • Carolina Guillot,
  • Amilcar A. Castellano-Sánchez,
  • Ana Maria Medina and
  • Vathany Sriganeshan
  • + 4 authors+ 0 author

17 January 2023

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. We evaluated the immunohistochemical (IHC) expression of p63 and p53 in DLBCL and their significance on overall survival (OS) and progression-free survival (PFS). We conduct...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
26 Citations
4,933 Views
17 Pages

Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma

  • Marion Alcantara,
  • Jaime Fuentealba and
  • Carole Soussain

10 October 2021

Primary central nervous system lymphoma (PCNSL) is, mainly, a diffuse large B-cell lymphoma (DLBCL) with a non-germinal center B-cell (non-GCB) origin. It is associated with a poor prognosis and an unmet medical need. Immunotherapy has emerged as one...

(This article belongs to the Special Issue Immunotherapy in B-cell Non-Hodgkin Lymphomas)
  • Systematic Review
  • Open Access
909 Views
25 Pages

Background/Objectives: High-grade B-cell lymphomas (HGBCLs) with MYC and BCL2 or BCL6 translocations, colloquially referred to as double-hit lymphomas (and abbreviated here to DHL), are aggressive malignancies. Differentiating DHL from non-DHL HGBCLs...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
29 Citations
9,163 Views
18 Pages

11 August 2021

Primary testicular lymphoma is a rare lymphoma entity, yet it is the most common testicular malignancy among elderly men. The majority of the cases represent non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma (DLBCL) with aggress...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
17 Citations
5,936 Views
15 Pages

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2

  • Verena Barbarino,
  • Sinika Henschke,
  • Stuart James Blakemore,
  • Elena Izquierdo and ,
  • Michael Michalik,
  • Nadine Nickel,
  • Indra Möllenkotte,
  • Daniela Vorholt,
  • Linda Müller and
  • Christian P. Pallasch
  • + 10 authors+ 5 authors

15 August 2020

Targeted inhibition of Bruton’s Tyrosine Kinase (BTK) with ibrutinib and other agents has become important treatment options in chronic lymphocytic leukemia, Waldenström’s Macroglobulinemia, Mantle cell lymphoma, and non-GCB DLBCL. Clinical trials co...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
38 Citations
7,968 Views
29 Pages

A Combination of Multilayer Perceptron, Radial Basis Function Artificial Neural Networks and Machine Learning Image Segmentation for the Dimension Reduction and the Prognosis Assessment of Diffuse Large B-Cell Lymphoma

  • Joaquim Carreras,
  • Yara Yukie Kikuti,
  • Masashi Miyaoka,
  • Shinichiro Hiraiwa and ,
  • Sakura Tomita,
  • Haruka Ikoma,
  • Yusuke Kondo,
  • Atsushi Ito,
  • Naoya Nakamura and
  • Rifat Hamoudi
  • + 5 authors+ 0 author

8 March 2021

The prognosis of diffuse large B-cell lymphoma (DLBCL) is heterogeneous. Therefore, we aimed to highlight predictive biomarkers. First, artificial intelligence was applied into a discovery series of gene expression of 414 patients (GSE10846). A dimen...

(This article belongs to the Special Issue Frontiers in Artificial Intelligence)
  • Article
  • Open Access
21 Citations
5,436 Views
17 Pages

Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining

  • Sarah Péricart,
  • Marie Tosolini,
  • Pauline Gravelle,
  • Cédric Rossi and ,
  • Alexandra Traverse-Glehen,
  • Nadia Amara,
  • Camille Franchet,
  • Elodie Martin,
  • Christine Bezombes and
  • Camille Laurent
  • + 8 authors+ 3 authors

31 October 2018

Therapeutic blockade of PD-1/PD-L1 shows promising results in Hodgkin’s lymphoma (HL) and in some diffuse large B-cell lymphoma (DLBCL) patients, but biomarkers predicting such responses are still lacking. To this end, we recently developed a t...

(This article belongs to the Special Issue Hodgkin's Lymphoma)
  • Article
  • Open Access
1 Citations
963 Views
12 Pages

Correlations Between Immunophenotypic Markers and Clinical Progression in Romanian Patients Diagnosed with Diffuse Large B-Cell Lymphoma

  • Georgian Halcu,
  • Anca Evsei-Seceleanu,
  • Dana-Antonia Tapoi,
  • Mihai Cerbu and ,
  • Cristian Barta and
  • Mihail Constantin Ceausu
  • + 1 author+ 0 author

Diffuse large B-cell lymphoma is a prevalent subtype of adult non-Hodgkin lymphoma; noted for its biological and clinical variability. Background and Objectives: This study seeks to assess the expression and prognostic implications of Ki-67, MYC, and...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
1 Citations
1,808 Views
24 Pages

Effects of Granulated Cork with Bark on the Microstructure and Resistance to Extreme Environmental Conditions of Concrete for Non-Structural Precast Elements

  • María Concepción Pacheco Menor,
  • María José Arévalo Caballero,
  • Antonio Macías García and
  • Pedro Serna Ros

21 February 2025

The building sector is responsible for major environmental impacts. Utilising bio-based raw materials, such as bio-aggregates, in concrete production could address to this environmental challenge. While the physical and mechanical properties of vario...

(This article belongs to the Special Issue Advance in Sustainable Construction Materials, Second Volume)
  • Article
  • Open Access
580 Views
14 Pages

Clinical Outcomes of Breast-Involved Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Real-World Study with Insights into CNS Prophylaxis

  • Thi Thu Huong Nguyen,
  • Thi Yen Le,
  • Thanh Tung Nguyen,
  • Thanh Long Nguyen and ,
  • Xuan Dai Nguyen,
  • Tuan Anh Pham,
  • Anh Tu Do,
  • Thi Thanh Ha Lai and
  • Van Quang Le
  • + 4 authors+ 0 author

This study evaluated clinical characteristics, treatment outcomes, and CNS relapse patterns in patients with breast-involved diffuse large B-cell lymphoma (DLBCL), a rare extranodal presentation with limited real-world data. We conducted a retrospect...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
6 Citations
4,475 Views
20 Pages

Intravascular Lymphoma: A Unique Pattern Underlying a Protean Disease

  • Mario Della Mura,
  • Joana Sorino,
  • Filippo Emanuele Angiuli,
  • Gerardo Cazzato and ,
  • Francesco Gaudio and
  • Giuseppe Ingravallo
  • + 1 author+ 0 author

15 July 2025

Intravascular lymphoma (IVL) is a rare, aggressive subtype of non-Hodgkin lymphoma (NHL) characterized by the selective proliferation of neoplastic lymphoid cells within small and medium-sized blood vessels, most frequently of B-cell origin (IVLBCL)....

(This article belongs to the Special Issue Advances in Pathology of Lymphoma and Leukemia)
  • Article
  • Open Access
352 Views
17 Pages

Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  • Vibor Milunović,
  • Maja Pučić-Baković,
  • Frano Vučković,
  • Ivana Duvnjak-Orešković and ,
  • Karla Mišura Jakobac,
  • Marin Kursar,
  • Inga Mandac Smoljanović,
  • Delfa Radić-Krišto and
  • Slavko Gašparov
  • + 4 authors+ 0 author

23 September 2026

Background: Diffuse large B-cell lymphoma (DLBCL) is a biologically heterogeneous lymphoma with variable clinical outcomes despite established molecular and clinical prognostic models. Immunoglobulin G (IgG) N-glycosylation regulates antibody effecto...

(This article belongs to the Special Issue Lymphomas: From Mechanisms to Therapeutic Approaches)
  • Article
  • Open Access
26 Citations
6,674 Views
13 Pages

Shear Strength of Geopolymer Concrete Beams Using High Calcium Content Fly Ash in a Marine Environment

  • Muhammad Sigit Darmawan,
  • Ridho Bayuaji,
  • Hidajat Sugihardjo,
  • Nur Ahmad Husin and
  • Raden Buyung Anugraha Affandhie

This paper deals with the behavior of a geopolymer concrete beam (GCB) under shear load using high calcium content fly ash (FA). The effect of the marine environment on the shear strength of GCB was considered by curing the specimen in a sea splashin...

(This article belongs to the Special Issue Ultra- and High-Performance Concrete—Experimental Behavior and Structural Computational Modelling and Design)
  • Article
  • Open Access
17 Citations
4,073 Views
16 Pages

Antioxidant and Sensory Properties of Raw and Cooked Pork Meat Burgers Formulated with Extract from Non-Compliant Green Coffee Beans

  • Monica Bergamaschi,
  • Nicoletta Simoncini,
  • Vincenzo Maria Spezzano,
  • Maura Ferri and
  • Annalisa Tassoni

16 March 2023

The effects of polyphenol-rich extract obtained from non-compliant defatted green coffee beans (dGCBs) on physicochemical and antioxidant properties, as well as on the sensory profile of vacuum-packed pork burgers stored at 4 °C for 14 days and a...

(This article belongs to the Section Meat)
  • Article
  • Open Access
6 Citations
6,650 Views
19 Pages

16 February 2022

This study aimed to investigate PD-L1 and PD-1 expression in circulating CD20+ cells in diffuse larger B-cell lymphoma (DLBCL) and to evaluate the predictive and diagnostic performance of PD-L1 versus PD-1 expression in circulating CD20+ cells in DLB...

  • Article
  • Open Access
1 Citations
1,178 Views
15 Pages

Molecularly Adapted Antitumor Therapy for Newly Diagnosed Diffuse Large B-Cell Lymphoma: Two-Year Follow-Up Results

  • Marat Mingalimov,
  • Elena Baryakh,
  • Andrey Misyurin,
  • Laura Kesaeva and ,
  • Hasmik Mkrtchyan,
  • Elena Misyurina,
  • Mariia Orlova,
  • Tatiana Tolstykh,
  • Ekaterina Zotina and
  • Mariana Lysenko
  • + 22 authors+ 17 authors

14 April 2026

Background/Objectives: Diffuse large B-cell lymphoma (DLBCL) is molecularly heterogeneous, and approximately 30-50% of patients fail to achieve cure with standard R-CHOP. Genotype-directed first-line therapy may improve outcomes by targeting subtype-...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
3 Citations
4,778 Views
15 Pages

Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma

  • Jessica Rodrigues Plaça,
  • Arjan Diepstra,
  • Tjitske Los,
  • Matías Mendeville and ,
  • Annika Seitz,
  • Pieternella J. Lugtenburg,
  • Josée Zijlstra,
  • King Lam,
  • Wilson Araújo da Silva and
  • Marcel Nijland
  • + 8 authors+ 3 authors

5 March 2022

Multiple gene expression profiles have been identified in diffuse large B-cell lymphoma (DLBCL). Besides the cell of origin (COO) classifier, no signatures have been reproduced in independent studies or evaluated for capturing distinct aspects of DLB...

(This article belongs to the Special Issue Molecular Characterization of Hematological Tumors)
  • Article
  • Open Access
3 Citations
856 Views
41 Pages

Background: Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent lymphomas. To date, it is not possible to identify which DLBCL patients will have an aggressive clinical evolution only by using hematoxylin and eosin (H&E) histologica...

(This article belongs to the Topic The Tumor Microenvironment, Immuno-Oncology, and Immune Checkpoint: Implications for Current and Emergent Immunotherapies, 2nd Edition)
  • Article
  • Open Access
22 Citations
6,189 Views
19 Pages

A Single Gene Expression Set Derived from Artificial Intelligence Predicted the Prognosis of Several Lymphoma Subtypes; and High Immunohistochemical Expression of TNFAIP8 Associated with Poor Prognosis in Diffuse Large B-Cell Lymphoma

  • Joaquim Carreras,
  • Yara Y. Kikuti,
  • Masashi Miyaoka,
  • Shinichiro Hiraiwa and ,
  • Sakura Tomita,
  • Haruka Ikoma,
  • Yusuke Kondo,
  • Atsushi Ito,
  • Sawako Shiraiwa and
  • Naoya Nakamura
  • + 7 authors+ 2 authors

21 July 2020

Objective: We have recently identified using multilayer perceptron analysis (artificial intelligence) a set of 25 genes with prognostic relevance in diffuse large B-cell lymphoma (DLBCL), but the importance of this set in other hematological neoplasi...

(This article belongs to the Special Issue Frontiers in Artificial Intelligence)
  • Article
  • Open Access
11 Citations
4,523 Views
17 Pages

Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter’s Trans-Formed DLBCL and Germinal Center B-Cells

  • Barbara Uhl,
  • Katharina T. Prochazka,
  • Katrin Pansy,
  • Kerstin Wenzl and ,
  • Johanna Strobl,
  • Claudia Baumgartner,
  • Marta M. Szmyra,
  • James E. Waha,
  • Axel Wolf and
  • Alexander J. Deutsch
  • + 19 authors+ 14 authors

Chemokine receptors and their ligands have been identified as playing an important role in the development of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and Richter syndrome (RS). Our aim was to investigate the different expression p...

(This article belongs to the Special Issue Tumor Microenvironment from a Precision Medicine Perspective 2.0)
  • Systematic Review
  • Open Access
1 Citations
749 Views
22 Pages

30 June 2026

Background/Objectives: Outcomes after CD19-directed chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (R/R) aggressive large B-cell lymphoma (aLBCL) remain heterogeneous. Tumor genomic biomarkers, such as TP53 alteration, MYC/...

(This article belongs to the Special Issue Advancements in Pharmacogenomics for Precision Medicine)
  • Article
  • Open Access
45 Citations
7,415 Views
32 Pages

Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel

  • Joaquim Carreras,
  • Shinichiro Hiraiwa,
  • Yara Yukie Kikuti,
  • Masashi Miyaoka and ,
  • Sakura Tomita,
  • Haruka Ikoma,
  • Atsushi Ito,
  • Yusuke Kondo,
  • Giovanna Roncador and
  • Naoya Nakamura
  • + 8 authors+ 3 authors

20 December 2021

Diffuse large B-cell lymphoma (DLBCL) is one of the most frequent subtypes of non-Hodgkin lymphomas. We used artificial neural networks (multilayer perceptron and radial basis function), machine learning, and conventional bioinformatics to predict th...

(This article belongs to the Special Issue Medical Imaging and Machine Learning​)
  • Review
  • Open Access
6 Citations
3,194 Views
26 Pages

Lipid Metabolism Reprogramming in Diffuse Large B-Cell Lymphoma (DLBCL): Mechanisms and Treatment Strategies

  • Yue-E Ding,
  • Yi-Ran Zhong,
  • Lai-Shun Zhang,
  • Lei Xu and ,
  • Jia Li and
  • Yi Wen
  • + 1 author+ 0 author

20 February 2026

Diffuse large B-cell lymphoma (DLBCL) is a common, aggressive non-Hodgkin lymphoma with significant molecular heterogeneity. This variability arises in part from its distinct molecular subtypes, including germinal center B-cell-like (GCB) DLBCL, acti...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
4 Citations
2,085 Views
34 Pages

3 February 2026

Diffuse large B-cell lymphoma (DLBCL) is the most frequent B-cell type of non-Hodgkin’s lymphoma. Recent genomic studies have highlighted the importance of genetic alterations in apoptotic pathways that help malignant DLBCL cells to evade apopt...

(This article belongs to the Special Issue Advancements in Hematology: Molecular Biology and Targeted Therapies)
  • Article
  • Open Access
6 Citations
3,568 Views
17 Pages

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL). Elevated expression of c-MYC in DLBCL is associated with poor prognosis of the disease. In different cancers, c-MYC has been found regulated by diffe...

(This article belongs to the Special Issue Natural Compounds in Modern Therapies)
  • Article
  • Open Access
6 Citations
4,251 Views
26 Pages

Artificial Intelligence Analysis and Reverse Engineering of Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using Gene Expression Data

  • Joaquim Carreras,
  • Yara Yukie Kikuti,
  • Masashi Miyaoka,
  • Saya Miyahara and ,
  • Giovanna Roncador,
  • Rifat Hamoudi and
  • Naoya Nakamura
  • + 2 authors+ 0 author

Diffuse large B-cell lymphoma is one of the most frequent mature B-cell hematological neoplasms and non-Hodgkin lymphomas. Despite advances in diagnosis and treatment, clinical evolution is unfavorable in a subset of patients. Using molecular techniq...

(This article belongs to the Special Issue Deep Learning Methods and Application for Bioinformatics and Healthcare)
  • Article
  • Open Access
3 Citations
3,296 Views
21 Pages

12 February 2023

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma and frequently develops through the accumulation of several genetic variations. With the advancement in high-throughput techniques, in addition to mutations and cop...

(This article belongs to the Special Issue Cancers: Genetics and Cellular Perspective)
  • Case Report
  • Open Access
2,593 Views
13 Pages

High Tumor Mutation Burden (TMB) and a Novel Somatic Mutation in the TREX1 Gene in a Patient with Aggressive and Refractory High-Grade B-Cell Lymphoma: A Case Report

  • Mariia Gusakova,
  • Fedor Sharko,
  • Eugenia Boulygina,
  • Natalia Slobodova and ,
  • Maria Gladysheva-Azgari,
  • Darima Badmazhapova,
  • Artem Bullikh,
  • Marina Khestanova,
  • Nelli Gabeeva and
  • Svetlana Tsygankova
  • + 7 authors+ 2 authors

High-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), is a rare entity within the spectrum of B-cell lymphomas. HGBL, NOS remains a diagnosis of exclusion with limited data available on the optimal clinical approach. We report a case of a...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
1,446 Views
14 Pages

Overexpression of CDCA2 in Diffuse Large B-Cell Lymphoma Promotes Cell Proliferation and Bortezomib Sensitivity

  • Hanne Due,
  • Asta Brogaard,
  • Issa Ismail Issa,
  • Maja Zimmer Jakobsen and ,
  • Cathrine Sylvester,
  • Anne Krogh Nøhr,
  • Louiza Bohn Thomsen,
  • Martin Kristian Thomsen,
  • Rasmus Froberg Brøndum and
  • Karen Dybkær
  • + 5 authors+ 0 author

Numerous clinical trials have attempted to improve first-line R-CHOP treatment of diffuse large B-cell lymphoma (DLBCL) through the addition or substitution of drugs. The REMoDL-B trial, testing the addition of bortezomib (RB-CHOP), revealed that ABC...

(This article belongs to the Section Molecular Oncology)
  • Brief Report
  • Open Access
4 Citations
3,224 Views
10 Pages

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

  • Emilio Bellitti,
  • Pierluigi Masciopinto,
  • Pellegrino Musto,
  • Elena Arcuti and ,
  • Luca Mastracci,
  • Giuseppina Opinto,
  • Sabino Ciavarella,
  • Attilio Guarini,
  • Gerardo Cazzato and
  • Giuseppe Ingravallo
  • + 8 authors+ 3 authors

25 August 2022

The metachronic onset of diffuse large B-cell lymphoma (DLBCL) after classic Hodgkin lymphoma (cHL) is a rare event affecting patients’ outcomes. However, although several studies have investigated the prognostic role of this event, little is k...

(This article belongs to the Special Issue Haematological Neoplasms: Diagnosis and Management)